+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cephalosporins"

From
Oral Antibiotics Market 2025-2033 - Product Thumbnail Image

Oral Antibiotics Market 2025-2033

  • Report
  • March 2025
  • 147 Pages
  • Global
From
Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029 - Product Thumbnail Image

Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 200 Pages
  • Global
From
From
Beta-Lactamase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-Lactamase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
Antibiotics Market Report 2023-2033 - Product Thumbnail Image

Antibiotics Market Report 2023-2033

  • Report
  • January 2023
  • 388 Pages
  • Global
From
Loading Indicator

Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from the fungus Cephalosporium and are closely related to penicillin. Cephalosporins are divided into four generations, each generation having a broader spectrum of activity than the previous one. They are used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. Cephalosporins are also used to treat some sexually transmitted diseases, such as gonorrhea. Cephalosporins are widely used in both human and veterinary medicine. They are available in a variety of formulations, including tablets, capsules, suspensions, and injections. Cephalosporins are generally well tolerated, with few side effects. Some companies in the Cephalosporins market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more